Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome

Céline Bar1, Gwenaelle Diene1,2, Catherine Molinas1,2,3

  • 1Endocrinology, Obesity, Bone Diseases, Genetics and Gynecology Unit, Children's Hospital, University Hospital Center of Toulouse, 330, avenue de Grande-Bretagne, TSA 40031 - 31059, Toulouse cedex 9, France.

Insights

Prader-Willi syndrome (PWS) affects 1 in 21,000 births in France, with many infants facing delayed diagnosis. Early detection and optimized neonatal care are crucial for managing this genetic disorder.

Area of Science:

  • Genetics
  • Neonatal Medicine
  • Neurodevelopmental Disorders

Background:

  • Prader-Willi syndrome (PWS) is a severe genetic disorder impacting neurodevelopment.
  • Diagnosis typically occurs in the neonatal period due to hypotonia and feeding issues.

Purpose of the Study:

  • To analyze the birth incidence of PWS in France.
  • To evaluate the care of infants diagnosed with PWS early in life.

Main Methods:

  • Data collected on 61 infants with molecularly confirmed PWS born in 2012-2013 in France.
  • Analysis of diagnostic timelines, clinical care, and birth incidence.

Main Results:

  • The 2013 birth incidence of PWS was 1/21,000.
  • Median age at diagnosis was 18 days; 5 infants experienced delayed diagnosis.
  • Most neonates required hospitalization (93%) and nasogastric tube feeding (84%).

Conclusions:

  • This study establishes the birth incidence of PWS in France.
  • Diagnostic delays occur due to unrecognized signs and suboptimal molecular testing.
  • There is a need to optimize neonatal care for infants with PWS.
Abstract

Related Concept Videos